Literature DB >> 20618065

Redox signaling regulates transcriptional activity of the Ca2+-dependent repressor DREAM.

Marcos Rivas1, Koldo Aurrekoetxea, Britt Mellström, José R Naranjo.   

Abstract

DREAM/KChIP3 (Downstream Regulatory Element Antagonist Modulator) is a multifunctional Ca(2+)-binding protein that acts in the nucleus as a Ca(2+)-dependent transcriptional repressor. Binding to DNA and repressor activity of DREAM is regulated by Ca(2+), specific post-translational modifications as well as by protein-protein interactions with several nucleoproteins. Here, using the yeast two-hybrid assay, we characterized the interaction of DREAM with peroxiredoxin 3 (Prdx3), an antioxidant enzyme that uses the thioredoxin system as electron donor. Importantly, the DREAM/Prdx3 interaction is Ca(2+) dependent and is blocked by DTT. Coexpression of Prdx3 enhances DREAM binding to DRE sites and its repressor activity in vivo. Two cysteine residues in the N-terminal domain of DREAM are responsible for the redox modulation of its activity. Double Cys to Ser substitution results in a mutant DREAM with stronger repressor activity. Finally, we show that transient DREAM knockdown sensitizes PC12 cells to H(2)O(2)-induced oxidative stress, suggesting a protective role for DREAM against oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618065     DOI: 10.1089/ars.2010.3385

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.

Authors:  José R Naranjo; Hongyu Zhang; Diego Villar; Paz González; Xose M Dopazo; Javier Morón-Oset; Elena Higueras; Juan C Oliveros; María D Arrabal; Angela Prieto; Pilar Cercós; Teresa González; Alicia De la Cruz; Juan Casado-Vela; Alberto Rábano; Carmen Valenzuela; Marta Gutierrez-Rodriguez; Jia-Yi Li; Britt Mellström
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

2.  The potassium channel interacting protein 3 (DREAM/KChIP3) heterodimerizes with and regulates calmodulin function.

Authors:  Pradeep L Ramachandran; Theodore A Craig; Elena A Atanasova; Gaofeng Cui; Barbara A Owen; H Robert Bergen; Georges Mer; Rajiv Kumar
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

3.  The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I.

Authors:  Theodore A Craig; Pradeep L Ramachandran; H Robert Bergen; Jewel L Podratz; Anthony J Windebank; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2013-03-21       Impact factor: 3.575

4.  DREAM controls the on/off switch of specific activity-dependent transcription pathways.

Authors:  Britt Mellström; Ignasi Sahún; Ana Ruiz-Nuño; Patricia Murtra; Rosa Gomez-Villafuertes; Magali Savignac; Juan C Oliveros; Paz Gonzalez; Asta Kastanauskaite; Shira Knafo; Min Zhuo; Alejandro Higuera-Matas; Michael L Errington; Rafael Maldonado; Javier DeFelipe; John G R Jefferys; Tim V P Bliss; Mara Dierssen; Jose R Naranjo
Journal:  Mol Cell Biol       Date:  2013-12-23       Impact factor: 4.272

5.  The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles.

Authors:  Karl H Braunewell
Journal:  Front Mol Neurosci       Date:  2012-02-23       Impact factor: 5.639

6.  Protein-Protein Interactions: Gene Acronym Redundancies and Current Limitations Precluding Automated Data Integration.

Authors:  Juan Casado-Vela; Rune Matthiesen; Susana Sellés; José Ramón Naranjo
Journal:  Proteomes       Date:  2013-05-31

7.  DREAM mediated regulation of GCM1 in the human placental trophoblast.

Authors:  Dora Baczyk; Mark Kibschull; Britt Mellstrom; Khrystyna Levytska; Marcos Rivas; Sascha Drewlo; Stephen J Lye; Jose R Naranjo; John C P Kingdom
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Reduced Mid1 Expression and Delayed Neuromotor Development in daDREAM Transgenic Mice.

Authors:  Mara Dierssen; Laura Fedrizzi; Rosa Gomez-Villafuertes; María Martinez de Lagran; Alfonso Gutierrez-Adan; Ignasi Sahún; Belen Pintado; Juan C Oliveros; Xose M Dopazo; Paz Gonzalez; Marisa Brini; Britt Mellström; Ernesto Carafoli; Jose R Naranjo
Journal:  Front Mol Neurosci       Date:  2012-05-03       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.